LEP and androgen insensitivity syndrome: Although resistin and leptin have been studied in relation to the risk of stroke and mortality in patients with AIS, our study is, to the best of our knowledge, the first to incorporate resistin into a validated predictive score for three-year mortality in AIS patients.